Hemodialysis is a blood filtration method for patients with kidney failure. A catheter is used to connect a patient to a dialysis machine in order to perform dialysis. Blood exchange catheter lumens (flexible tubular passage) are colored red and blue for easy identification during the dialysis procedure. The red-colored lumen (atrial lumen) transfers blood from the patient to the dialysis machine for filtration, while the blue-colored lumen (venous lumen) returns blood to the patient after the dialysis machine filtration. A catheter is advanced into the chest by inserting it into one of the large veins, such as the superior vena cava, or by puncturing the internal jugular vein in the neck. The range of blood flow through a catheter is 200 to 500 milliliters per minute. There are cuffed tunneled catheters, non-cuffed tunneled catheters, and non-tunneled catheters available for hemodialysis catheters.
Patients are compelled to use dialysis products and services as the incidence of kidney diseases rises, which drives demand for hemodialysis catheters. Catheters for hemodialysis provide temporary vascular access to correct metabolic imbalances caused by renal dysfunction. Permanent vascular access is recommended for dialysis due to its lower complication rates and greater efficacy; however, the demand for catheters continues to rise due to various patient health factors. Increasing age and comorbid conditions, such as diabetes and vascular disease, can inhibit the formation and maintenance of fistulas and grafts in patients. The delay in referral to a nephrologist for the creation of an arteriovenous fistula (AFV) and the failure of fistulas or grafts are some of the reasons for the continued use of hemodialysis catheters. Consequently, the increase in hemodialysis catheter usage is anticipated to drive the market for chronic hemodialysis catheters over the forecast period.
Home hemodialysis is a hemodialysis technique that can be performed in the home. Home hemodialysis has numerous benefits, including the ability to perform treatment more frequently and for longer periods of time without interruption. There are two types of home hemodialysis treatments: short, daily hemodialysis and traditional, four-hour sessions performed up to three times per week. Home hemodialysis provides patients with greater control over dialysis and improves their quality of life. The cumulative prevalence of in-center hemodialysis is likely to compel hemodialysis patients to switch to home hemodialysis in order to better manage the dialysis process. It is anticipated that the expansion of personalized users will increase hemodialysis catheter sales.
Asia Pacific region is the highest contributor to the market and is expected to grow at a CAGR of 4.2% during the forecast period. As a result of a rise in demand for hemodialysis catheter products, improved health awareness, advancements in healthcare infrastructure, an increase in the number of dialysis centers with advanced medical facilities, a surge in healthcare reforms, and an increase in the number of dialysis patients in emerging economies, the hemodialysis catheter market is projected to grow. Increased prevalence of chronic kidney disease and associated risk factors, such as diabetes, cardiovascular diseases, and hypertension, increased utilization of hemodialysis catheter products, and an increase in the number of patients receiving hemodialysis treatment is driving the growth of the market in this region. The increased emphasis of leading manufacturers on expanding their geographic presence in emerging Asia-Pacific nations to capitalize on high growth opportunities also contributes to the growth of the market. In addition, China is anticipated to grow at the highest CAGR during the forecast period due to the presence of the largest population, a significant surge in demand for advanced medical facilities, and an increase in R&D activities in the region's healthcare industry.
North America is expected to witness dynamic growth in the Chronic Hemodialysis Catheter market, with a CAGR of 3.7% during the forecast period. This is primarily due to technological advancements in dialysis equipment and hemodialysis catheter, a rise in the prevalence of chronic kidney disease (CKD), and an increase in the number of dialysis patients. Approximately 15% of U.S. adults had chronic kidney disease (CKD) in 2019, according to the Centers for Disease Control and Prevention. In addition, an increase in demand for hemodialysis catheter products, the presence of technologically advanced healthcare facilities with trained medical professionals, and a rise in the number of research and development centers all significantly contribute to the growth of the North American market. In addition, the market is driven by a high incidence of chronic kidney disease, the presence of a large geriatric population, the ease of availability of hemodialysis catheter products, favorable reimbursement policies, and a rise in consumer awareness of their use.
Europe is expected to witness a significant CAGR of 2.3% in the chronic hemodialysis catheter market during the forecast period due to an increase in patient awareness of hemodialysis treatment, a large number of hospitals with trained medical personnel, an increase in the number of dialysis centers, and the presence of a large population of hemodialysis patients. The chronic hemodialysis catheter market in Germany, France, and the United Kingdom is anticipated to expand substantially due to the presence of a large number of key players and a developed healthcare infrastructure with technologically advanced systems. The chronic hemodialysis catheter market in European countries is anticipated to expand at a steady rate during the period of forecast, owing to the growing demand for advanced hemodialysis catheter products and the dominance of key players. Additionally, technological advances in dialysis equipment and catheter technology, a shortage of kidney donors for transplantation, and a high adoption rate of hemodialysis products all contribute to the growth of the market in this region. In addition, the presence of developed healthcare infrastructure and the availability of trained professionals are significant growth drivers for the European market.
The LAMEA region is expected to witness a moderate CAGR of 2.8% in the global chronic hemodialysis catheter market during the forecast period. LAMEA is an emerging market that is anticipated to provide lucrative growth opportunities for key players as a result of the increase in the target population, the surge in demand for hemodialysis catheter products, and the improvement of healthcare infrastructure. In addition, the increase in the number of patients with end-stage renal disease (ESRD) in LAMEA drives the adoption of hemodialysis catheter products, thereby driving the growth of the market.
The global chronic hemodialysis catheter market's major key players are AngioDynamics, Inc., Dickinson and Company, Fresenius SE and Co. KGaA, B. Braun Holding GmbH & Co. KG, Baxter International Inc., Becton, Medtronic Plc., Nikkiso Co. Ltd., Medical Components, Inc. Nipro Medical Corporation, and Teleflex Incorporated.